淋巴细胞白血病-话题@MedSci

#淋巴细胞白血病#

277篇内容 | 4820人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1998024, encodeId=efc3199802408, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=AJH：治疗和未治疗的慢性淋巴细胞白血病患者的第二原发恶性肿瘤发生率对比, objectType=article, longId=218215, objectId=3d1e21821536, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3d1e21821536, replyNumber=0, likeNumber=59, createdTime=2022-03-28, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3d1e21821536, moduleTitle=AJH：治疗和未治疗的慢性淋巴细胞白血病患者的第二原发恶性肿瘤发生率对比, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3d1e21821536)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1998023, encodeId=97f81998023c0, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Lancet Haemat：发生急性淋巴细胞白血病的唐氏综合征患儿的预后, objectType=article, longId=218055, objectId=1a5821805589, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1a5821805589, replyNumber=0, likeNumber=99, createdTime=2021-10-08, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1a5821805589, moduleTitle=Lancet Haemat：发生急性淋巴细胞白血病的唐氏综合征患儿的预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1a5821805589)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1998001, encodeId=e022199800103, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=治疗急性淋巴细胞白血病，合源生物CAR-T疗法拟纳入突破性治疗品种, objectType=article, longId=204505, objectId=f42b2045051f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f42b2045051f, replyNumber=0, likeNumber=63, createdTime=2021-02-17, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f42b2045051f, moduleTitle=治疗急性淋巴细胞白血病，合源生物CAR-T疗法拟纳入突破性治疗品种, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f42b2045051f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1998013, encodeId=b91d19980130b, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Blood：TLR9，慢性淋巴细胞白血病的新治疗靶点！, objectType=article, longId=212576, objectId=7c4b2125e69a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7c4b2125e69a, replyNumber=0, likeNumber=92, createdTime=2022-02-15, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7c4b2125e69a, moduleTitle=Blood：TLR9，慢性淋巴细胞白血病的新治疗靶点！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7c4b2125e69a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1998002, encodeId=af2319980027b, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Blood：Notch信号促进慢性淋巴细胞白血病发生发展, objectType=article, longId=204758, objectId=6792204e58f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6792204e58f4, replyNumber=0, likeNumber=106, createdTime=2021-10-27, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6792204e58f4, moduleTitle=Blood：Notch信号促进慢性淋巴细胞白血病发生发展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6792204e58f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1998017, encodeId=ba7c199801ea9, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=J Clin Oncol：供体来源CD7嵌合抗原受体T细胞治疗急性T淋巴细胞白血病的未来可期！, objectType=article, longId=215210, objectId=517621521090, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=517621521090, replyNumber=0, likeNumber=104, createdTime=2022-01-06, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=517621521090, moduleTitle=J Clin Oncol：供体来源CD7嵌合抗原受体T细胞治疗急性T淋巴细胞白血病的未来可期！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=517621521090)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1998014, encodeId=f2c0199801448, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Leukemia：iFCG化疗方案治疗携带IGHV突变且无TP53突变的慢性淋巴细胞白血病, objectType=article, longId=212646, objectId=63c52126468a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=63c52126468a, replyNumber=0, likeNumber=68, createdTime=2021-11-03, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=63c52126468a, moduleTitle=Leukemia：iFCG化疗方案治疗携带IGHV突变且无TP53突变的慢性淋巴细胞白血病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=63c52126468a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997999, encodeId=4f44199e999cb, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=阿斯利康的BTK抑制剂Calquence：欧洲获批治疗慢性淋巴细胞白血病, objectType=article, longId=203214, objectId=c984203214b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c984203214b8, replyNumber=0, likeNumber=104, createdTime=2021-06-18, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c984203214b8, moduleTitle=阿斯利康的BTK抑制剂Calquence：欧洲获批治疗慢性淋巴细胞白血病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c984203214b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1998011, encodeId=32511998011a0, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle= Blood：Inotuzumab ozogamicin用于复发/难治性小儿急性淋巴细胞白血病的疗效, objectType=article, longId=209725, objectId=06c7209e2530, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=06c7209e2530, replyNumber=0, likeNumber=76, createdTime=2022-02-19, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=06c7209e2530, moduleTitle= Blood：Inotuzumab ozogamicin用于复发/难治性小儿急性淋巴细胞白血病的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=06c7209e2530)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1998005, encodeId=922119980055a, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Nat Commun：全基因组关联研究鉴定慢性淋巴细胞白血病的危险基因座, objectType=article, longId=206849, objectId=767b206849b4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=767b206849b4, replyNumber=0, likeNumber=62, createdTime=2021-04-27, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=767b206849b4, moduleTitle=Nat Commun：全基因组关联研究鉴定慢性淋巴细胞白血病的危险基因座, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=767b206849b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997992, encodeId=9b45199e99200, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Blood：慢性淋巴细胞白血病刻板化亚型之间的高阶联系, objectType=article, longId=201682, objectId=c4a92016821f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c4a92016821f, replyNumber=0, likeNumber=69, createdTime=2021-07-16, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c4a92016821f, moduleTitle=Blood：慢性淋巴细胞白血病刻板化亚型之间的高阶联系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c4a92016821f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997988, encodeId=9b06199e98872, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Blood：ETV6介导性儿童急性淋巴细胞白血病易感性的分子基础, objectType=article, longId=198721, objectId=7089198e216c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7089198e216c, replyNumber=0, likeNumber=68, createdTime=2020-12-29, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7089198e216c, moduleTitle=Blood：ETV6介导性儿童急性淋巴细胞白血病易感性的分子基础, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7089198e216c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1998006, encodeId=26fe199800654, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Cancer Discov：Venetoclax+Navitoclax+化疗治疗复发/难治性急性淋巴细胞白血病和淋巴母细胞淋巴瘤, objectType=article, longId=207301, objectId=436420e30131, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=436420e30131, replyNumber=0, likeNumber=77, createdTime=2021-06-03, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=436420e30131, moduleTitle=Cancer Discov：Venetoclax+Navitoclax+化疗治疗复发/难治性急性淋巴细胞白血病和淋巴母细胞淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=436420e30131)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1998012, encodeId=8f6a1998012d0, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=急性淋巴细胞白血病药物临床试验中检测微小残留病的技术指导原则, objectType=article, longId=209942, objectId=434e20994255, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=434e20994255, replyNumber=0, likeNumber=73, createdTime=2021-10-30, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=434e20994255, moduleTitle=急性淋巴细胞白血病药物临床试验中检测微小残留病的技术指导原则, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=434e20994255)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1998008, encodeId=9b4f1998008b2, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Lancet Haematol：依鲁替尼加用Ublituximab可显著提高复发性/难治性慢性淋巴细胞白血病患者的缓解率, objectType=article, longId=207517, objectId=3e5020e5170d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3e5020e5170d, replyNumber=0, likeNumber=80, createdTime=2022-01-15, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3e5020e5170d, moduleTitle=Lancet Haematol：依鲁替尼加用Ublituximab可显著提高复发性/难治性慢性淋巴细胞白血病患者的缓解率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3e5020e5170d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997986, encodeId=2ce9199e986de, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Brit J Heamatol：T细胞大颗粒性淋巴细胞白血病的临床结局, objectType=article, longId=196795, objectId=2109196e95bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2109196e95bc, replyNumber=0, likeNumber=61, createdTime=2020-07-11, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2109196e95bc, moduleTitle=Brit J Heamatol：T细胞大颗粒性淋巴细胞白血病的临床结局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2109196e95bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1998007, encodeId=cc1c199800ec0, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Blood：BH3图谱分析发现ruxolitinib可与ventoclax联合治疗前体T淋巴细胞白血病, objectType=article, longId=207368, objectId=dbc020e368b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dbc020e368b8, replyNumber=0, likeNumber=118, createdTime=2021-09-23, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dbc020e368b8, moduleTitle=Blood：BH3图谱分析发现ruxolitinib可与ventoclax联合治疗前体T淋巴细胞白血病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dbc020e368b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997998, encodeId=48ea199e998c4, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=达沙替尼-博纳吐单抗治疗成人ph+急性淋巴细胞白血病, objectType=article, longId=202422, objectId=f58020242298, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f58020242298, replyNumber=0, likeNumber=81, createdTime=2021-01-21, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f58020242298, moduleTitle=达沙替尼-博纳吐单抗治疗成人ph+急性淋巴细胞白血病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f58020242298)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997993, encodeId=645b199e9931c, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Blood：家族性B细胞前体-急性淋巴细胞白血病的胚系PAX5突变, objectType=article, longId=201968, objectId=46da2019686d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=46da2019686d, replyNumber=0, likeNumber=85, createdTime=2020-11-25, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=46da2019686d, moduleTitle=Blood：家族性B细胞前体-急性淋巴细胞白血病的胚系PAX5突变, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=46da2019686d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1998004, encodeId=e8a21998004df, content=<a href='/topic/show?id=75ff66001cd' target=_blank style='color:#2F92EE;'>#淋巴细胞白血病#</a>, objectTitle=Blood：TLR9，慢性淋巴细胞白血病的新潜在治疗靶点！, objectType=article, longId=205500, objectId=18f9205500da, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=18f9205500da, replyNumber=0, likeNumber=35, createdTime=2021-01-11, rootId=0, userName=sunyl07, userId=1be8234, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=18f9205500da, moduleTitle=Blood：TLR9，慢性淋巴细胞白血病的新潜在治疗靶点！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=18f9205500da)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

淋巴细胞白血病

2020-05-29

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

AJH：治疗和未治疗的慢性淋巴细胞白血病患者的第二原发恶性肿瘤发生率对比

2022-03-28

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Lancet Haemat：发生急性淋巴细胞白血病的唐氏综合征患儿的预后

2021-10-08

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

治疗急性淋巴细胞白血病，合源生物CAR-T疗法拟纳入突破性治疗品种

2021-02-17

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Blood：TLR9，慢性淋巴细胞白血病的新治疗靶点！

2022-02-15

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Blood：Notch信号促进慢性淋巴细胞白血病发生发展

2021-10-27

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

J Clin Oncol：供体来源CD7嵌合抗原受体T细胞治疗急性T淋巴细胞白血病的未来可期！

2022-01-06

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Leukemia：iFCG化疗方案治疗携带IGHV突变且无TP53突变的慢性淋巴细胞白血病

2021-11-03

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

阿斯利康的BTK抑制剂Calquence：欧洲获批治疗慢性淋巴细胞白血病

2021-06-18

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Blood：Inotuzumab ozogamicin用于复发/难治性小儿急性淋巴细胞白血病的疗效

2022-02-19

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Nat Commun：全基因组关联研究鉴定慢性淋巴细胞白血病的危险基因座

2021-04-27

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Blood：慢性淋巴细胞白血病刻板化亚型之间的高阶联系

2021-07-16

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Blood：ETV6介导性儿童急性淋巴细胞白血病易感性的分子基础

2020-12-29

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Cancer Discov：Venetoclax+Navitoclax+化疗治疗复发/难治性急性淋巴细胞白血病和淋巴母细胞淋巴瘤

2021-06-03

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

急性淋巴细胞白血病药物临床试验中检测微小残留病的技术指导原则

2021-10-30

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Lancet Haematol：依鲁替尼加用Ublituximab可显著提高复发性/难治性慢性淋巴细胞白血病患者的缓解率

2022-01-15

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Brit J Heamatol：T细胞大颗粒性淋巴细胞白血病的临床结局

2020-07-11

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Blood：BH3图谱分析发现ruxolitinib可与ventoclax联合治疗前体T淋巴细胞白血病

2021-09-23

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

达沙替尼-博纳吐单抗治疗成人ph+急性淋巴细胞白血病

2021-01-21

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Blood：家族性B细胞前体-急性淋巴细胞白血病的胚系PAX5突变

2020-11-25

sunyl07 (审核中...)

前往app查看评论内容

#淋巴细胞白血病#

Blood：TLR9，慢性淋巴细胞白血病的新潜在治疗靶点！

2021-01-11

科室
- - 订阅+
  - 更多科室
工具
服务